Latest Regulatory Approvals News

Cooper Metals reports promising exploration progress at its Mt Isa East copper-gold project and high-grade gold assays at the Gooroo project, while maintaining a solid cash reserve of $2.1 million.

Bioxyne Limited has reported a remarkable 77% jump in revenue for Q2 FY2025, alongside positive operating cash flow, as it prepares to expand manufacturing capacity and enter new international markets.

Dropsuite Limited has entered a binding Scheme Implementation Deed with NinjaOne for a $420 million all-cash acquisition at $5.90 per share, representing a significant premium to recent trading prices. The deal, supported unanimously by Dropsuite’s board and largest shareholder, awaits shareholder and regulatory approvals.

OzAurum Resources has made significant strides in its Mulgabbie North Gold Project feasibility study, fully funded by Line Hydrogen Pty Ltd, aiming for a near-term cashflow positive trial operation.

3D Energi Limited is progressing rapidly towards its 2025 Otway Exploration Drilling Program, with key preparations underway and regulatory approvals advancing, positioning the company to potentially capitalise on East Coast Australia's critical gas supply shortage.

Energy Resources of Australia (ERA) reports a robust cash position following a $766 million entitlement offer, advancing rehabilitation at its Ranger Project while seeking to extend its operational authority beyond January 2026.

Bioxyne Limited reports a remarkable 77% revenue increase in Q2 FY2025 alongside positive operating cash flow, setting the stage for international growth with upcoming UK export approvals and a planned European GMP facility.

A1 Investments & Resources Ltd reported minimal cash flow activity for the December 2023 quarter while actively pursuing renewable energy acquisition opportunities in Japan and Australia.

Empire Energy has successfully drilled its longest well to date, secured a $65 million financing package, and received environmental approval for its Carpentaria Pilot Project, setting the stage for first gas deliveries later in 2025.

EMVision Medical Devices reports strong progress in clinical trials for its emu™ Bedside Scanner, backed by robust cash reserves and strategic non-dilutive funding. The company is poised to commence pivotal FDA validation trials, marking a key step toward commercialisation.

Terramin's December 2024 quarterly report reveals major progress at its Tala Hamza Zinc Project with land acquisition and a $336 million EPC contract, while the Bird in Hand Gold Project faces a legal hurdle after the Supreme Court dismissed its mining lease application.

Zelira Therapeutics has received a fourth funding tranche, bringing total investment to US$3.25 million to support FDA clinical trials of its HOPE® 1 cannabinoid medicine targeting irritability in autism spectrum disorder and Phelan-McDermid Syndrome.